Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Viking Therapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
VKTX
Nasdaq
2830
www.vikingtherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Viking Therapeutics, Inc.
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?
- Jun 29th, 2026 9:10 am
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
- Jun 29th, 2026 7:30 am
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
- Jun 26th, 2026 9:25 am
Viking Therapeutics (VKTX) Starts First Human Obesity Trial For VK3019
- Jun 25th, 2026 5:10 pm
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Jun 25th, 2026 3:45 pm
VKTX Stock Jumps on Phase I Study Initiation for New Obesity Drug
- Jun 25th, 2026 7:57 am
VKTX Stock Eyes Best Week In 2 Years: Retail Bulls Bet Q3 Obesity Data Could Put Novo, Big Pharma In Buyout Play
- Jun 24th, 2026 10:14 pm
VKTX Stock On Track For Five Consecutive Days Of Gains — Viking Launches Human Trial For Novel Obesity Drug VK3019
- Jun 24th, 2026 12:57 pm
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
- Jun 24th, 2026 5:05 am
Viking Therapeutics (VKTX) Soars Higher — Medicare Could Hold The Answer
- Jun 23rd, 2026 8:12 pm
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation
- Jun 23rd, 2026 5:46 pm
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?
- Jun 23rd, 2026 8:34 am
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
- Jun 23rd, 2026 5:55 am
Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
- Jun 22nd, 2026 10:50 pm
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
- Jun 22nd, 2026 6:35 pm
Set It and Forget It: 2 Consumer Stocks to Hold for the Next 20 Years
- Jun 22nd, 2026 9:40 am
Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know
- Jun 17th, 2026 3:50 pm
Viking Therapeutics (VKTX) Offers Potential With VK2735 Market Opportunity
- Jun 17th, 2026 9:55 am
Viking Therapeutics CMO Hire Puts Spotlight On Pipeline Progress And Valuation
- Jun 12th, 2026 2:17 am
Is Viking Therapeutics Stock Going to $100?
- Jun 11th, 2026 11:35 pm
Scroll